collaboration

R&D

Looking to the future of clinical trials: Gene therapy, prec...

Next-generation technologies in medicine have significantly expanded our ability to identify and address rare diseases, propelling forwards the development of more effective and targeted tr

Market Access

True innovation in life sciences is only possible through a ...

Many of the biggest life sciences breakthroughs are the result of European research.

Digital

AI and the human touch: Embracing a symbiotic future

How long is your current to-do list?

Patients

Partnerships for prevention: Biopharma, patients, and digita...

Anthropy23 returned to The Eden Project in Cornwall for its second year in November, once more bringing together cross-industry companies and individuals united in a shared goal: to seek su

Market Access

Understanding the complex rare disease and specialty pharmac...

Donovan Quill, AscellaHealth’s Executive Vice President of Growth and Strategy, describes the unique challenges associated with bringing new specialty and rare disease pharmaceutical produc

R&D

The importance of collaboration in tackling the ethical conc...

Cell and gene therapies (CGT) offer immense potential for healthcare – opening up countless possibilities for saving and improving lives, which were previously unavailable through existing